ReP USP - Resultado da busca

Artigo de periodico
Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics (2023)
Perez-Vargas, Jimena ; Shapira, Tirosh ; Olmstead, Andrea D ; Villanueva, Ivan ; Thompson, Connor A. H; Ennis, Siobhan ; Gao, Guang; Guzman, Joshua De; Williams, David E ; Wang, Meng; Chin, Aaleigha; Bautista-Sanchez, Diana ; Agafitei, Olga ; Levett, Paul; Xie, Xuping; Nuzzo, Genoveffa ; Freire, Vitor Fernandes ; Bulla, Jairo L Quintana ; Bernardi, Darlon Irineu ; Gubiani, Juliana Regina ; Suthiphasilp, Virayu; Raksat, Achara; Meesakul, Pornphimol ; Polbuppha, Isaraporn; Cheenpracha, Sarot ; Jaidee, Wuttichai ; Kanokmedhakul, Kwanjai; Yenjai, Chavi; Chaiyosang , Boonyanoot; Teles, Helder Lopes; Manzo, Emiliano; Fontana, Angelo ; Leduc, Richard; Boudreault, Pierre-Luc ; Berlinck, Roberto Gomes de Souza ; Laphookhieo, Surat; Kanokmedhakul, Somdej; Tietjen, Ian; Cherkasov, Artem; Krajden, Mel ; Nabi, Ivan Robert ; Niikura, Masahiro; Shi, Pei-Yong; Andersen, Raymond J; Jean, Francois
Source: Antiviral Research. Unidades: IQSC, ESALQ
Subjects: ANTIVIRAIS, COVID-19, PANDEMIAS, PRODUTOS NATURAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREZ-VARGAS, Jimena et al. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics. Antiviral Research, v. 209, p. 1-13, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.antiviral.2022.105484. Acesso em: 28 abr. 2024.
APA
Perez-Vargas, J., Shapira, T., Olmstead, A. D., Villanueva, I., Thompson, C. A. H., Ennis, S., et al. (2023). Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics. Antiviral Research, 209, 1-13. doi:10.1016/j.antiviral.2022.105484
NLM
Perez-Vargas J, Shapira T, Olmstead AD, Villanueva I, Thompson CAH, Ennis S, Gao G, Guzman JD, Williams DE, Wang M, Chin A, Bautista-Sanchez D, Agafitei O, Levett P, Xie X, Nuzzo G, Freire VF, Bulla JLQ, Bernardi DI, Gubiani JR, Suthiphasilp V, Raksat A, Meesakul P, Polbuppha I, Cheenpracha S, Jaidee W, Kanokmedhakul K, Yenjai C, Chaiyosang B, Teles HL, Manzo E, Fontana A, Leduc R, Boudreault P-L, Berlinck RG de S, Laphookhieo S, Kanokmedhakul S, Tietjen I, Cherkasov A, Krajden M, Nabi IR, Niikura M, Shi P-Y, Andersen RJ, Jean F. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics [Internet]. Antiviral Research. 2023 ; 209 1-13.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1016/j.antiviral.2022.105484
Vancouver
Perez-Vargas J, Shapira T, Olmstead AD, Villanueva I, Thompson CAH, Ennis S, Gao G, Guzman JD, Williams DE, Wang M, Chin A, Bautista-Sanchez D, Agafitei O, Levett P, Xie X, Nuzzo G, Freire VF, Bulla JLQ, Bernardi DI, Gubiani JR, Suthiphasilp V, Raksat A, Meesakul P, Polbuppha I, Cheenpracha S, Jaidee W, Kanokmedhakul K, Yenjai C, Chaiyosang B, Teles HL, Manzo E, Fontana A, Leduc R, Boudreault P-L, Berlinck RG de S, Laphookhieo S, Kanokmedhakul S, Tietjen I, Cherkasov A, Krajden M, Nabi IR, Niikura M, Shi P-Y, Andersen RJ, Jean F. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics [Internet]. Antiviral Research. 2023 ; 209 1-13.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1016/j.antiviral.2022.105484
Artigo de periodico
SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients (2022)
Pontelli, Marjorie C.; Castro, Ítalo A.; Martins, Ronaldo B; La Serra, Leonardo; Veras, Flávio P.; Nascimento, Daniele C; Silva, Camila M.; Cardoso, Ricardo S; Rosales, Roberta Ribeiro Costa; Gomes, Rogério; Lima, Thais M.; Souza, Juliano P.; Vitti, Brenda C.; Caetité, Diego B.; Lima, Mikhael Haruo Fernandes de; Stumpf, Spencer D; Thompson, Cassandra E; Bloyet, Louis-Marie; Toller-Kawahisa, Juliana E.; Giannini, Marcela C.; Bonjorno, Letícia P; Lopes, Maria Isabel Fernandes; Batah, Sabrina Setembre; Siyuan, Li; Luppino-Assad, Rodrigo; Almeida, Sergio C L; Oliveira, Fabiola R; Benatti, Maíra N; Pontes, Lorena Lobo de Figueiredo; Santana, Rodrigo Carvalho; Vilar, Fernando C; Auxiliadora-Martins, Maria; Shi, Pei-Yong; Cunha, Thiago Mattar; Calado, Rodrigo Tocantins; Alves-Filho, José Carlos; Zamboni, Dario Simões; Fabro, Alexandre Todorovic; Louzada Júnior, Paulo; Oliveira, Renê Donizete Ribeiro; Whelan, Sean P J; Cunha, Fernando Queiróz; Arruda, Eurico
Source: Journal of Molecular Cell Biology. Unidades: FCFRP, FMRP
Subjects: COVID-19, LINFÓCITOS, MONÓCITOS, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONTELLI, Marjorie C. et al. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients. Journal of Molecular Cell Biology, v. 14, n. 4, 2022Tradução . . Disponível em: https://doi.org/10.1093/jmcb/mjac021. Acesso em: 28 abr. 2024.
APA
Pontelli, M. C., Castro, Í. A., Martins, R. B., La Serra, L., Veras, F. P., Nascimento, D. C., et al. (2022). SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients. Journal of Molecular Cell Biology, 14( 4). doi:10.1093/jmcb/mjac021
NLM
Pontelli MC, Castro ÍA, Martins RB, La Serra L, Veras FP, Nascimento DC, Silva CM, Cardoso RS, Rosales RRC, Gomes R, Lima TM, Souza JP, Vitti BC, Caetité DB, Lima MHF de, Stumpf SD, Thompson CE, Bloyet L-M, Toller-Kawahisa JE, Giannini MC, Bonjorno LP, Lopes MIF, Batah SS, Siyuan L, Luppino-Assad R, Almeida SCL, Oliveira FR, Benatti MN, Pontes LL de F, Santana RC, Vilar FC, Auxiliadora-Martins M, Shi P-Y, Cunha TM, Calado RT, Alves-Filho JC, Zamboni DS, Fabro AT, Louzada Júnior P, Oliveira RDR, Whelan SPJ, Cunha FQ, Arruda E. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients [Internet]. Journal of Molecular Cell Biology. 2022 ; 14( 4):[citado 2024 abr. 28 ] Available from: https://doi.org/10.1093/jmcb/mjac021
Vancouver
Pontelli MC, Castro ÍA, Martins RB, La Serra L, Veras FP, Nascimento DC, Silva CM, Cardoso RS, Rosales RRC, Gomes R, Lima TM, Souza JP, Vitti BC, Caetité DB, Lima MHF de, Stumpf SD, Thompson CE, Bloyet L-M, Toller-Kawahisa JE, Giannini MC, Bonjorno LP, Lopes MIF, Batah SS, Siyuan L, Luppino-Assad R, Almeida SCL, Oliveira FR, Benatti MN, Pontes LL de F, Santana RC, Vilar FC, Auxiliadora-Martins M, Shi P-Y, Cunha TM, Calado RT, Alves-Filho JC, Zamboni DS, Fabro AT, Louzada Júnior P, Oliveira RDR, Whelan SPJ, Cunha FQ, Arruda E. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients [Internet]. Journal of Molecular Cell Biology. 2022 ; 14( 4):[citado 2024 abr. 28 ] Available from: https://doi.org/10.1093/jmcb/mjac021
Artigo de periodico
Zika in the americas, year 2: what have we learned? What gaps remain? A report from the global virus network (2017)
Aliota, Matthew T; Bassit, Leda; Bradrick, Shelton S.; Cox, Bryan; Blanco, Mariano A. Garcia; Gavegnano, Christina; Friedrich, Thomas C.; Golos, Thaddeus G; Griffin, Diane E; Haddow, Andrew D; Kallás, Esper Georges; Kitron, Uriel; Lecuit, Diogo M; Magnani, Diogo M; Marrs, Caroline; Mercer, Natalia; McSweegan, Edward; Ng, Lisa F. P; O'connor, David H; Osorio, Jorge E; Ribeiro, Guilherme S; Ricciardi, Michael; Rossi, Shannan L; Saade, George; Schinazi, Raymond F; Lerner, Geraldine O. Schott; Shan, Chao; Shi, Pei-Yong; Watkins, David I; Vasilakis, Nikos; Weaver, Scott C
Source: Antiviral research. Unidade: FM
Subjects: ZIKA VÍRUS, TRANSMISSÃO DE DOENÇAS, GRAVIDEZ, VACINAS VIRAIS, FETO, MALFORMAÇÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALIOTA, Matthew T et al. Zika in the americas, year 2: what have we learned? What gaps remain? A report from the global virus network. Antiviral research, v. 144, p. 223-226, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.antiviral.2017.06.001. Acesso em: 28 abr. 2024.
APA
Aliota, M. T., Bassit, L., Bradrick, S. S., Cox, B., Blanco, M. A. G., Gavegnano, C., et al. (2017). Zika in the americas, year 2: what have we learned? What gaps remain? A report from the global virus network. Antiviral research, 144, 223-226. doi:10.1016/j.antiviral.2017.06.001
NLM
Aliota MT, Bassit L, Bradrick SS, Cox B, Blanco MAG, Gavegnano C, Friedrich TC, Golos TG, Griffin DE, Haddow AD, Kallás EG, Kitron U, Lecuit DM, Magnani DM, Marrs C, Mercer N, McSweegan E, Ng LFP, O'connor DH, Osorio JE, Ribeiro GS, Ricciardi M, Rossi SL, Saade G, Schinazi RF, Lerner GOS, Shan C, Shi P-Y, Watkins DI, Vasilakis N, Weaver SC. Zika in the americas, year 2: what have we learned? What gaps remain? A report from the global virus network [Internet]. Antiviral research. 2017 ; 144 223-226.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1016/j.antiviral.2017.06.001
Vancouver
Aliota MT, Bassit L, Bradrick SS, Cox B, Blanco MAG, Gavegnano C, Friedrich TC, Golos TG, Griffin DE, Haddow AD, Kallás EG, Kitron U, Lecuit DM, Magnani DM, Marrs C, Mercer N, McSweegan E, Ng LFP, O'connor DH, Osorio JE, Ribeiro GS, Ricciardi M, Rossi SL, Saade G, Schinazi RF, Lerner GOS, Shan C, Shi P-Y, Watkins DI, Vasilakis N, Weaver SC. Zika in the americas, year 2: what have we learned? What gaps remain? A report from the global virus network [Internet]. Antiviral research. 2017 ; 144 223-226.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1016/j.antiviral.2017.06.001

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration